Log In
BCIQ
Print this Print this
 

Bcr-Abl/Lyn

  Manage Alerts
Collapse Summary General Information
Company AB Science S.A.
DescriptionBCR-ABL tyrosine kinase/Lyn kinase (LYN) inhibitor
Molecular Target BCR-ABL tyrosine kinase (BCR-ABL) ; Lyn kinase (LYN)
Mechanism of ActionBCR-ABL tyrosine kinase inhibitor; Lyn kinase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAcute myelogenous leukemia (AML)
Indication DetailsTreat acute myelogenous leukemia (AML)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today